Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1-Methylimidazole | HCID 1390 | — |
| Reactant | Methanesulfonyl chloride | HCID 31297 | — |
| Reactant | Melanin-concentrating hormone | HCID 16167454 | — |
| Reactant | HCID 86761244 | HCID 86761244 | — |
| Reactant | HCID 86761245 | HCID 86761245 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 57877635 | HCID 57877635 | — |
Reaction Steps
1-Benzyl 3-methyl (3R)-4-{[1-(3-ethoxyphenyl)-2-(4-methylphenyl)-1H-imidazol-4-yl]carbonyl}piperazine-1,3-dicarboxylate To a solution of 3.18 g (9.88 mmol) of Intermediate 1 in 75 mL of anhydrous dichloromethane at 0° C. was added 1.5 mL (19 mmol) of 1-methylimidazole followed by 0.80 mL (9.9 mmol) of methanesulfonyl chloride. The resulting mixture was stirred with gradual warming to ambient temperature over 20 min, then re-cooled to 0° C. A solution of 2.39 g (8.59 mmol) of 1-benzyl 3-methyl-(3R)-piperazine-1,3-dicarboxylate in 25 mL of anhydrous dichloromethane was then added and the reaction mixture was allowed to warm to ambient temperature over 1 h. The reaction was then quenched with a saturated aqueous ammonium chloride solution (25 mL) and the layers were separated. The aqueous layer was extracted with dichloromethane (2×100 mL) and the combined organic layers were washed with brine (50 mL), dried over magnesium sulfate, filtered and concentrated in vacuo. The crude residue was purified on a Biotage® purification apparatus (silica gel, 40 to 50% ethyl acetate in hexanes gradient) to yield the title compound as a colorless solid. LC/MS 583.5 (M+1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07858629B2 |
|---|
| Source dataset | uspto-grants-2010_12 |
|---|
| ORD ID | ord-56afdc8b46b84be8924b54708caa3a11 |
|---|
| Source note | uspto-grants-2010_12 |
|---|